Home/Filings/4/0001209191-23-059009
4//SEC Filing

Ropp Sam 4

Accession 0001209191-23-059009

CIK 0001850906other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:44 PM ET

Size

7.3 KB

Accession

0001209191-23-059009

Insider Transaction Report

Form 4
Period: 2023-12-15
Ropp Sam
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-12-154,18854,437 total
    Common Stock (4,188 underlying)
  • Exercise/Conversion

    Common Stock

    2023-12-15+4,18812,563 total
Footnotes (3)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.

Issuer

Singular Genomics Systems, Inc.

CIK 0001850906

Entity typeother

Related Parties

1
  • filerCIK 0001973313

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:44 PM ET
Size
7.3 KB